We have located links that may give you full text access.
Journal Article
Review
How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases.
Annals of Translational Medicine 2023 April 16
Autoantibodies are associated with neuroimmune diseases that affect the central and peripheral nervous systems. There are many methods for detecting autoantibodies, among which cell-based assay (CBA) is a relatively novel and important technology that is widely used. CBAs, as novel indirect immunofluorescence assays with known antigen epitopes, have revolutionized the identification of autoantibodies compared with the traditional immunoassays, such as the radioimmunoprecipitation and enzyme-linked immunosorbent assays, as well as the tissue-based assays (TBAs). However, the results of the same sample might exhibit obvious differences between different laboratories, or among repeated testing in the same laboratory, which influence the sensitivity and specificity in the diagnostic performance for a specific neuroimmune disease. In this paper, we review the establishment of CBA technology, and discuss potential interfering factors in CBA methods on its sensitivity and specificity for the autoantibodies associated with neuroimmune diseases.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app